Optimizing drug therapy in patients with cardiovascular disease: the impact of pharmacist-managed pharmacotherapy clinics in a primary care setting (Q28193213)

From Wikidata

Jump to navigation Jump to search

scientific article (publication date: June 2002)

Language	Label	Description	Also known as
English	Optimizing drug therapy in patients with cardiovascular disease: the impact of pharmacist-managed pharmacotherapy clinics in a primary care setting	scientific article (publication date: June 2002)

Statements

scholarly article

0 references

Optimizing drug therapy in patients with cardiovascular disease: the impact of pharmacist-managed pharmacotherapy clinics in a primary care setting (English)

0 references

pharmacotherapy

0 references

cardiovascular disease

1 reference

based on heuristic

inferred from title

author name string

Jean Geber

1

0 references

David Parra

2

0 references

Nick P Beckey

3

0 references

Lisa Korman

4

0 references

language of work or name

0 references

publication date

June 2002

0 references

Pharmacotherapy

0 references

22

0 references

6

0 references

738-47

0 references

Executive Summary of The Third Report of The National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, And Treatment of High Blood Cholesterol In Adults (Adult Treatment Panel III)

1 reference

https://api.crossref.org/works/10.1592/PHCO.22.9.738.34061

20 April 2017

A comparison of enalapril with hydralazine-isosorbide dinitrate in the treatment of chronic congestive heart failure

1 reference

https://api.crossref.org/works/10.1592/PHCO.22.9.738.34061

20 April 2017

Prevention of coronary heart disease with pravastatin in men with hypercholesterolemia. West of Scotland Coronary Prevention Study Group

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.22.9.738.34061

20 April 2017

Patterns of aspirin use in middle-aged adults: the Atherosclerosis Risk in Communities (ARIC) Study

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.22.9.738.34061

21 January 2018

Secondary prevention in coronary heart disease: baseline survey of provision in general practice

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.22.9.738.34061

21 January 2018

Management of hypercholesterolemia: practice patterns for primary care providers and cardiologists

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.22.9.738.34061

21 January 2018

Treatment patterns and distribution of low-density lipoprotein cholesterol levels in treatment-eligible United States adults

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.22.9.738.34061

21 January 2018

Risk reduction therapies for patients with coronary artery disease: a call for increased implementation

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.22.9.738.34061

21 January 2018

Temporal patterns in the medical treatment of congestive heart failure with angiotensin-converting enzyme inhibitors in older adults, 1989 through 1995.

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.22.9.738.34061

21 January 2018

National patterns of angiotensin-converting enzyme inhibitor use in congestive heart failure.

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.22.9.738.34061

21 January 2018

Cholesterol lowering in the management of coronary artery disease: the clinical implications of recent trials

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.22.9.738.34061

21 January 2018

Serum cholesterol levels are underevaluated and undertreated

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.22.9.738.34061

21 January 2018

Overview of atherosclerosis

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.22.9.738.34061

21 January 2018

Management of patients with chronic stable angina at low risk for serious cardiac events

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.22.9.738.34061

21 January 2018

Aspirin and other platelet-active drugs. The relationship among dose, effectiveness, and side effects

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.22.9.738.34061

21 January 2018

Effects of enalapril on mortality in severe congestive heart failure. Results of the Cooperative North Scandinavian Enalapril Survival Study (CONSENSUS).

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.22.9.738.34061

21 January 2018

Effect of enalapril on survival in patients with reduced left ventricular ejection fractions and congestive heart failure

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.22.9.738.34061

21 January 2018

Effect of captopril on mortality and morbidity in patients with left ventricular dysfunction after myocardial infarction. Results of the survival and ventricular enlargement trial. The SAVE Investigators

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.22.9.738.34061

21 January 2018

Toleration of high doses of angiotensin-converting enzyme inhibitors in patients with chronic heart failure: results from the ATLAS trial. The Assessment of Treatment with Lisinopril and Survival

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.22.9.738.34061

21 January 2018

Comparison of an anticoagulation clinic with usual medical care: anticoagulation control, patient outcomes, and health care costs.

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.22.9.738.34061

21 January 2018

Pharmacist participation on physician rounds and adverse drug events in the intensive care unit

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.22.9.738.34061

21 January 2018

Comparative dose efficacy study of atorvastatin versus simvastatin, pravastatin, lovastatin, and fluvastatin in patients with hypercholesterolemia (the CURVES study)

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.22.9.738.34061

21 January 2018

Effectiveness of chart prompts to improve physician compliance with the National Cholesterol Education Program guidelines

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.22.9.738.34061

21 January 2018

Effects of computer-based clinical decision support systems on physician performance and patient outcomes: a systematic review.

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.22.9.738.34061

21 January 2018

Effect of enalapril on mortality and the development of heart failure in asymptomatic patients with reduced left ventricular ejection fractions

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.22.9.738.34061

21 January 2018

Identifiers

10.1592/PHCO.22.9.738.34061

0 references

PubMed publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q28193213&oldid=1241025474"